Skip to content

Author

E. Siddiqui

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Prevalence of smartphone addiction and its association with anxiety and depression among pregnant women in Pakistan: A cross-sectional study.

BackgroundExcessive smartphone use has emerged as a growing public health concern and has been associated with anxiety, depression, and adverse behavioral outcomes. Although smartphone addiction (SA) has been widely studied in adolescents and young adults, limited evidence exists regarding its prevalence and psychologi...

Laiba Akram, M. S. Khan, E. Siddiqui et al. · 0 citations
Meta-analysis Open access Jan 2026

Safety and Efficacy of Asundexian in Cardiovascular Diseases, Updated Systemic Review and Meta Analysis.

BackgroundThromboembolic events remain a major cause of morbidity and mortality in cardiovascular diseases. Asundexian, an oral factor XIa inhibitor, has been proposed to reduce thrombosis while minimizing bleeding risk. The recent OCEANIC-STROKE trial provided substantial new evidence. We conducted an updated systemat...

E. Siddiqui, Noor Ahmad, Simrn Majid et al. · 0 citations
Review Sep 2026

Efficacy and Safety of Linaclotide in Pediatric Patients of Functional Constipation: A Meta-analysis of Randomized Controlled Trials.

OBJECTIVE To evaluate the efficacy and safety of linaclotide in children with functional constipation (FC) by synthesizing evidence from randomized controlled trials (RCTs). DATA SOURCES A systematic search of PubMed, Scopus, Cochrane Central Register of Controlled Trials, and Google Scholar was conducted from incept...

M. S. Khan, Humayou Ahmed, E. Siddiqui et al. · 0 citations
Review Sep 2026

Effect of Temporary Methotrexate Discontinuation on Vaccine Immunogenicity and Disease Flare in Rheumatoid Arthritis: A Systematic Review.

BACKGROUND Methotrexate (MTX) is a cornerstone disease-modifying antirheumatic drug for rheumatoid arthritis (RA); however, it may attenuate vaccine-induced immune responses. Temporary MTX interruption around vaccination has been proposed to improve immunogenicity, but concerns remain regarding disease flare and safety...

Ayesha Tahir, Ammara Iftikhar, Kashaw Kumar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.